| Description | Miridesap (GSK2315698) is a divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance. It also produces significant reduction of SAP from cerebrospinal fluid and visceral amyloid deposits |
| Synonyms | Ro63-8695, CPHPC, GSK2315698 |
| molecular weight | 340.37 |
| Molecular formula | C16H24N2O6 |
| CAS | 224624-80-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 75 mg/mL (220.35 mM) |
| References | 1. Bodin K , Ellmerich S , Kahan M C , et al. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits[J]. NATURE, 2010, 468(7320):93-97. |